98%
921
2 minutes
20
This study was conducted in a descriptive and cross-sectional design to determine the physical health status of individuals with substance use disorders receiving inpatient treatment at an addiction treatment center. Data were collected between April 2023 and April 2024 at the Adult Detoxification Center of a psychiatric hospital in Istanbul, Türkiye. The sample consisted of a total of 261 individuals with substance use disorders (218 males and 43 females) who met the inclusion criteria. Data were collected using the Personal Information Form and the Health Improvement Profile. The most common physical illness among people with substance use disorders is cardiovascular disease. Significant gender-based differences were observed across multiple health domains. In the measurement subscale, women had significantly higher pulse rates compared to men. In the blood test subscale, mean total cholesterol (TC) and low-density lipoprotein (LDL) levels were also significantly higher among women. The screening subscale revealed significant gender differences in dental and eye examinations, breast self-examination, presence of constipation and/or diarrhea, as well as gastrointestinal symptoms, such as bloating, distention, or the need for laxative use. Similarly, lifestyle-related variables-including physical activity, daily alcohol and carbohydrate intake, fluid consumption, cannabis use, and engagement in safe sexual practices-differed significantly by gender. It is important to diagnose, monitor, and risk assess the physical health of individuals with substance use disorders. Therefore, mental health and psychiatric nurses should emphasize physical diagnosis and provide a holistic approach to individuals with substance use disorders.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/15332640.2025.2553334 | DOI Listing |
J Behav Health Serv Res
September 2025
Department of Counselor Education, Fairfield University, Fairfield, CT, USA.
This qualitative study explores what factors influence teaming in behavioral health settings, from the perspective of behavioral health providers. Twenty-four participants from a range of behavioral health professions engaged in semi-structured interviews. Using a grounded theory approach, data were analyzed, and a "prism" model was developed to capture the complexities of behavioral health providers' perceptions of factors influencing teaming in various mental health and/or substance use disorder treatment programs.
View Article and Find Full Text PDFMol Psychiatry
September 2025
Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
Pharmacological modulation of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) through dual GIP/GLP-1 receptor agonists, commonly used for diabetes and obesity, shows promise in reducing alcohol consumption. We applied drug-target Mendelian randomization (MR) using genetic variation at these loci to assess their long-term effects on problematic alcohol use (PAU), binge drinking, alcohol misuse classifications, liver health, and other substance use behaviors. Genetic proxies for lowered BMI, modeling the appetite-suppressing and weight-reducing effects of variants in both the GIPR and GLP1R loci ("GIPR/GLP1R"), were linked with reduced binge drinking in the primary (β = -0.
View Article and Find Full Text PDFJ Am Acad Psychiatry Law
September 2025
Dr. Dernbach is a medical toxicologist and current addiction psychiatry fellow, Department of Psychiatry, Harvard Medical School, Boston, MA. Dr. Appel is a Professor of Psychiatry and Medical Education, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY.
Clinicians face the prospect of mandated reporting when a patient reports, either during the intake appointment or during the course of addiction treatment, their risky substance use-related behavior around a child. Beyond legal considerations, many factors might influence a clinician's decision whether or not to report the case to child protective services (CPS). Although there is literature regarding mandated reporting in the setting of pre- or perinatal substance use, there is limited literature regarding the mandated reporting obligation in the setting of postnatal substance use around children.
View Article and Find Full Text PDFEcotoxicol Environ Saf
September 2025
Department of Nephrology, Chang Gung Memorial Hospital, Keelung Branch, 222, Mai-Chin Road, Keelung 20401, Taiwan; College of Medicine, Chang Gung University, No. 259, Wenhua 1st Rd., Guishan Dist, Taoyuan City, Taipei 33302, Taiwan; Community Medicine Research Center, Chang Gung Memorial Hospital,
Per- and polyfluoroalkyl substances (PFAS) are a large class of synthetic chemicals widely used in industrial and consumer applications, known for their environmental persistence, bioaccumulation, and potential toxicity. Mounting toxicological evidence suggests that the kidney is a primary target organ for PFAS accumulation, yet human data regarding compound-specific renal effects remain limited. In this community-based prospective cohort study, we investigated the associations between serum PFAS concentrations and renal outcomes in 257 adults, including 48 with chronic kidney disease (CKD) and 209 with normal kidney function at baseline.
View Article and Find Full Text PDF